Главная страница

МОНОГРАФИЯ Гепатит и последствия гепатита. Майер К.-П (в word). Гепатит и последствия гепатита Практич рук. Пер с нем. Под ред. А. А. Шепулина. М. Гэотар медицина, 1999. 432 с


Скачать 6.25 Mb.
НазваниеГепатит и последствия гепатита Практич рук. Пер с нем. Под ред. А. А. Шепулина. М. Гэотар медицина, 1999. 432 с
АнкорМОНОГРАФИЯ Гепатит и последствия гепатита. Майер К.-П (в word).doc
Дата23.03.2017
Размер6.25 Mb.
Формат файлаdoc
Имя файлаМОНОГРАФИЯ Гепатит и последствия гепатита. Майер К.-П (в word).doc
ТипДокументы
#4114
КатегорияМедицина
страница48 из 49
1   ...   41   42   43   44   45   46   47   48   49

Sci 27 (1982) 103

14-3 АСЦИТ И ОСЛОЖНЕНИЯ АСЦИТА
\ndreau, М , R Sola, A Sitges-Serra, С Aha, М Gallen, М С Vila, S Coil, М I Oliver Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites Gastro-enterology 104 (1993) 1133-1138

Birkenfeld, L W , J Leibman, M P O'Meara, 1 S Edelman Total exchangeable sodium, total exchangeable potas­sium, and total body water in edematous patients with cirrhosis of the liver J elm Invest 37(1958) 687-698

aly,WR,E Strauss A prospective study of bacterial infections inpatients with cirrhosis J Hepatol 18(1993) 353-358

Epstein, M Natriuretic hormone and the sodium retention of cirrhosis Gastroenterology 81 (1981) 395-397 Oentilini, P, G Laffi Pathophysiology and treatment of ascites and the hepatorenal syndrome In Clinical

Gastroenterology 6 (1992) p 581 3erbes, A L Medical treatment of ascites in cirrhosis J Hepatol 17 (Suppl) 2 (1993) S4-S9 3ines, P , V Arroyo Paracentesis in the management of cirrhotic ascites J Hepatol (Suppl) 2 (1993) S14-S18 3ines, P, V Arroyo, E Quintero, R Planas, F Bory, J Cabrera, A Rimola, J Viver, J Camps, W Gimenez,

R Mastai, J Gaya, J Rodes Comparison of paracentesis and diuretics in the treatment of cirrhotics with

tense ascites Gastroenterology 93 (1987) 234-241 3ines, P, L Tito, V Arroyo, R Planas, J Panes, J Viver, M Torres, P Humbert, A Rimola, J Llach, S

Badalamenti, W Jimenez, J Gaya, J Rodes Randomized comparative study of therapeutic paracentesis

with and without intravenous Albumin in cirrhosis Gastroenterology 94 (1988) 1493-1502 jines, A , A Escorsell, P Gines, J Salo, W Jimenez, L lnglada, M Navasa, J Clana, A Rimola, V Arroyo,

J Rodes Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

Gastroenterology 105 (1993) 229-236

Gines, А, J М Salmeron, Р Gines, V Arroyo, W Jimenez, F Rivera, J Rodes Oral misoprostol or intrave­nous prostaglan-din Es do not improve renal function in patients with cirrhosis and ascites with hyponatre­mia or renal failure J Hepatol 17 (1993) 220-226

Ilerzog, P,C Walther, К II Holtermuller Natnumgehalt flnssiger Antacidum-Praparate Dtsch med Wschr 112 (1987) 302-304

ltingst, D , A L Gerbes, R Martin, G Paumgartner Value of ascitic cholesterol in the differentiation between cirrhotic and malignant ascites Hepatology 6 (1986) 239-243

Kramer, H J Diagnose des hepatorenalen Syndroms Dtsch med Wschr 113 (1988a) 558-560

Kramer, II J Therapie des hepatorenalen Syndroms Dtsch med Wschr 113 (1988 b) 561-564

Kuo, С II , CS Chang-Chien, С Y Yang, 1 S Sheen, Y F Liaw Bacteremia in patients with cirrhosis of the liver Liver 11 (1991) 334-339

Lenz, К , II Hortnagt, W Drumi, II Reither, R Schmid, В Schneeweiss, An Laggner, G Grimm, A L Ger­bes Orni-pression in the treatment of functional renal failure m decom-pensated liver cirrhosis Effects on renal hemodynamics and atrial natriuretic factor Gastroenterology 101 (1991) 1060-1067

Maier, К -P Die Behandlung des therapierefraktaren Aszites Inn Med 10 (1983) 291-298

Mirouze, D , R D Zipser, T В Reynolds Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis Hepatology 3 (1983) 50-55

Moore, К , J Wendon, M Frazer, J Karani, R Williams, К Badr Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome New Engl J Med 327 (1992)1774-1778

Pinto, P С , J Amenan, T В Reynolds Large-volume paracentesis in nonedematous patients with tense ascites its effect on intravascular volume Hepatology 8 (1988) 207-210

Pockros, P J , T В Reynolds Rapid diuresis in patients with ascites from chronic liver disease the importance of peripheral edema Gastroenterology 90 (1986) 1827-1833

Press, A G , К H Meyerzum Bnschenfelde, G Ramadon Die spontane baktenelle Peritonitis Z Gastroen­terol 30 (1992) 543-552

Probst, T , A Propst, G Schauer, G Judmaier, II Braunstei-ner, W Vogel Spontane baktenelle Peritonitis bei chroni-scher Lebererkrankung mit Aszites Dtsch med Wschr 118 (1993) 943-946

Richardet, J P , M Beaugrand Infection pentoneale spontan-nee chez le cirrhotique Gastroenterol clin biol 15 (1991) 239-249

Runyon, В A Low-protein-concentration ascitic fluid is predisposed to spontaneous bactenal peritonitis Gastroenterology 91 (1986) 1343-1346

Safirstein, R , M F Levitt A hepatorenal depressor reflex A possible clue to the pathogenesis of the hepatore­nal syndrome Hepatology 14(1991) 734

Savli, II, II Pnstaut, G Zach, A Eherer F Schreiber, G J Krejs Spontaneous bacterial peritonitis a senous problem in patients with ascites Europ J Gastroenterol Hepatol 4 (1991)165-171

Scholmench, J Diagnostik und Therapie des Aszites Internist 28 (1987) 448-458

Scholmench, J , В A Volk, E Kottgen, S Ehlers, W Gerok Fibronectin concentration in aszites differentiales between malignant and nonmalignant aszites Gastroenterology 87 (1984) 1160-1164

Scholmench, J , E Fnck, S Hollerbach Konservative Therapie des Ascites Chirurg 64 (1993) 7-10

Shear, L , S Ching, G J Gabudza Compartmentalization of ascites and edema in patients with hepatic cirrho­sis New Engl J Med 282 (1970)1391-1396

Tito, L , A Rimola, P Gines, J Llach, V Arroyo, J Rodes Recurrence of spontaneous bactenal peritonitis in cirrhosis frequency and predictive factors Hepatology 8 (1988) 27-31

Toledo, С , J M Salmeron, A Rimola, M Navasa, V Arroyo, J Llach, A Gines, P Gines, J Rodes Spontane­ous bacterial peritonitis in cirrhosis Predictive factors of infection resolution and survival in patients treated with cefotaxime Hepatology 17 (1993) 251-257

Zipser, R D , J Kronborg, W Rector, T Reynolds, G Daska-lopoulos Therapeutic trial of thromboxane syn­thesis inhibition in the hepatorenal syndrome Gastroenterology 87 (1984) 1228-1232

14-4 ГЕПАТОЦЕЛЛЮЛЯРНАЯ КАРЦИНОМА
Barbara L , Benzi G , Gaiam S , Fusconi F , Zironi G , Sinngo S , Rigamonti С , Barbara С , Gngioni W , Mazzi-otti A , Bolondi L Natural history of small untreated hepatocellular carcinoma in cirrhosis a multivanate analysis of prognostic factors of tumor growth rate and patient survival Hepatology 16 (1992) 132-137

Calvet, X , Bruix, J , Gines, P et al Prognostic factors of hepatocellular carcinoma in the west a multivariate analysis in 206 patients Hepatology 12 (1990) 753-760

Okuda, К , Ohtsuki, T , Obata, H , Tomimatsu, M , Okazaki, N, Hasegawa, II , Nakajima, Y , Ohnishi, К Natural history of hepatocellular carcinoma and prognosis in relation to treatment Study of 850 patients Cancer 56 (1985) 918-928

Cottone, M , Virdone, R , Fusco, G , Orlando, A Turn, M , Cahagirone, M , Mannghini, A, Sciarnno, E, Demma, 1 , Nicoli, N , Tine, F , Sammarco, S , Pagliaro, L Asymptomatic hepatocellular carcinoma in Child's A Cirrhosis A comparison of natural history and surgical treatment Gastroenterology 96 (1989) 1566-157

Barbara, L , Benzi, G , Gaiani, S , Fuscom, F , Zironi, G , Sinngo, S , Rigamonti, A , Barbara, С , Gngiom, W , Mazziotti, A , Bolondi, L Natural history of small untreated hepatocellular carcinoma m cirrhosis a multi­variate analysis of prognostic factors of tumor growth rate and patient survival Hepatology 16 (1992) 132-137

Ebara, M , Ohto, M , Shinagawa, T , Sugmra, N , Kimura, К , Matsutam, S , Monta, M , et al Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis Gastroenterolo­gy 90 (1986) 289-298

Yamanaka, N , Okamoto, E , Onyama, T , Fujimoto, J , Furukawa, К , Kawamura, E, Tanaka, T , Tomoda, F A prediction scoring system to select the surgical treatment of liver cancer Annals of Surgery 219 (1994) 342-346

Tsao, JI, Lofthus, JP, Nagomey, DM, Adson, MA, Ilstrup, DM Trends in morbidity and mortality of hepatic resection for malignancy a matched corparative analysis Ann Surg 220 (1994) 199-205

Zieren, J , Zieren, HU, Muller, JM Leberresektion wegen pnmarer Mahgnome Eigene Ergebmsse und Liter-aturanalyse Langenbecks Arch Chir 379 (1994) 159-167

Roh, MS Recent progress in the treatment of hepatocellular carcinoma Curr Opm Oncol 2 (1990) 725-730

Nagasue, N , Khono, II, Chang, YC, Tamura, II, Yamanoi, A , Uchida, M , et al Liver resection for hepato­cellular carcinoma result of 229 consecutive patients during 11 years Ann Surg 217 (1993), 375-384

Chen, MF, Hwamng, TL, Jeng, LB, Wang CS, Jan YY, Chen SC Postoperative recurrence of hepatocellular carcinoma two hundred five consecutive patients who underwent hepatic resection in 15 years Arch Surg 129 (1994) 738-742

Tang, ZY, Ye-Qm, Y U, Xin-Da, Z , Zeng-Chen, M , Rong, Y , Ji-Zhen, L , Zhi-Ying, L , Bmg-Hui, Y Surgery of small hepatocellular carcinoma Analysis of 144 cases Cancer 64 (1989) 536-541

Lise, M , Bacchetti, S , Da Pian, P , Nitti, D , Pilati PL, Pigato, P Prognostic factors affecting long term out­come after liver resection for hepatocellular carcinoma Cancer 82 (1998) 1028-1036,

Livraghi, T , et al No treatment, resection andethanol injection in hepatocellular carcinoma JHepatol 22(1995) 522-526

Takenaka, К , Kawahara, N , Yamamoto, K, Kajiyama, К , Maeda, T , Itasaka, II, et al Results of 280 liver

resections for hepatocellular carcinoma Arch Surg 131 (1996) 71-76 The Liver Cancer Study Group of Japan Primary liver cancer in Japan chmcopathologic features and results of

surgical treatment Ann Surg 211 (1990) 277-287 Muto, Y , Monwaki, H , Ninomiya, M , Adachi, S , Sarto, A , Takasaki, KT, Tanaka, T , Tsurumi К , Okuno,

M , Tomita, E , Nakamura, T , Kojima, T for the hepatoma prevention study group Prevention of second

primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma N Engi

J Med 334 (1996) 1561-1567 Pichlmayr, R , Weimann, A , Oldhafer, KJ, Schhtt, IU, Klempnauer, J , Bomscheuer, A , Chavan, A , Schmoll,

E , Lang, H , Tusch, G , Ringe, В Role of liver transplantation in the treatment of unresectable liver cancer

World J Surg 19 (1995) 807-813 Schwartz, ME, Sung, M , Мог, E , Fisher, A , Popescu, I , Fiel, I , Sheiner, P , Emre, S , Guy, S , Miller, CM A

multidisciphnary approach to hepatocellular carcinoma m patients with cirrhosis J Am Coil Surg 180 (1995)

596-603

Mazzaferro, V , Regalia, E , Doci, R , Andreola, S , Pulvirenti, A , Bozzetti, F , Montalto, F , Ammatuna, M , Morabito, A , German, L Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engi J Med 334 (1996) 693-699

Bismuth, H , Chiche, L , Adam, R , Castamg, D , Diamond, T , Denmson, A Liver resection versus transplan­tation for hepatocellular carcinoma in cirrhotic patients Ann Surg 218 (1993) 613-618

Yu, Y, Xu, D , Zhou, X , Lu JZ, Tang, ZY, Mack, P Experience with liver resection after hepatic arterial chemoembohzation for hepatocellular cancer Cancer 71 (1993) 62-65

Stone, MJ, Goran, GB, Polter, KD, Husberg, BS, Mennel, RG, Ramsay, MA, Flemens, EE, Goldstein, RM Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma a pilot study in 20 pa­tients Gastroenterology 104(1993) 196-202

Lai, CL, Wu, PC, Chan, GC, Lok, AS, Lm, HJ Doxorubicin versus no antitumor therapy m inoperable hepato­cellular carcinoma Cancer 62 (1988) 479-483

Lai, CL, Wu, PC, Lok, AS, Lin, HJ, Ngan, II, Lau, JY, Chung, HA, Arnold, M Recombinant (x-mterferon is superior to doxorubicin for inoperable hepatocellular carcinoma a prospective randomised trial Brit J Cancer 60 (1989) 928-933

Wallner, I, Hartmann, H , Ramadori, G Aktuelle Therapiestrategien fur das hepatozellulare Karzmom Leber Magen Darm 24 (1994) 150-154, 189-201

Manesis, EK, Giannouhs, G , Zomboulis, P , Vafiadou, I, Hadziyannis, SJ Treatment of hepatocellular carci­noma with combined suppression and inhibition of sex hormaones a randomized, controlled trial Hepato-logy21 (1995) 1535-1542

Cheirsilpa, A , Leelasethakul, S , Auethaveekiat, V , Maoleekukpnoj, S , Kangsumnt, N, Thanaiaravit, P, Phantumjida, P High-dose mitomycm-C activity in hepatocellular carcinoma Cancer Chemother Phan-nacol 24 (1989) 50-53

Falkson, G , Ryan, LM, Johnson, LA, simson, IW A randomized phase II study of mitoxantrone and cisplatm in patients with hepatocellular carcinoma An ECOG study Cancer 60 (1987) 2141-2145

Fannati, F , Salvagmm, M , de Maria, N , Fomasiero, A , Chiaramonte, M , Rossaro, L , Naccararo, R Unresec­table hepatocellular carcinoma a prospective controlled trial with tamoxifen J Hepatol 11 (1990) 297-301

Martmez-Cerezo, FJ, Tomas, A , Donoso, L, Ennquez, J , Guamer, С , Balanzo, J , Martmez-Nogueras, A , Vilardell, F Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma J Hepatol 20 (1994) 702-706

Castells, A , Bmtx, J . Bru, С , Ayuso, С , Roca, M , Biox, L , Vilana, R , Rodes, J Treatment of hepatocellular carcinoma with tamoxifen a double-blind placebo-controlled trial in 120 patients Gastroenterology 109 (1995) 917-922

Elba, S , Giannuzzi, V , Misciagna, G , Manghisi, OG Randomized controlled trial of tamoxifen versus place­bo in inoperable hepatocellular carcinoma Ital J Gastroenterol 26 (1994) 66-68

Buckley, MMT, Hoa, KL Tamoxifen a reappnsal on its pharmacodynamic and pharacokmetic properties and therapeutic use Dmgs 37 (1989) 451-490

Brian, CA, Word, NE, Anderson, BW Role of specific interactions between peotetn kinase С and tnphenyle-thylenes in inhibition of the enzyme J Nati Cancer mst 29 (1988) 1628-1633

Matsuda, S , Kadowaki, Y , Ichmo, M I7beta estradiol mimics hgand activity of the c-erbB2 protooncogene product Proc Nati Acad Sci USA 90 (1984) 10803-10806

Fabian, С , Stemson, L , El-Serafi, M , Cam, L , Heame, E Clinical pharmacology of tamoxifen in patients with breast cancer correlation with clinical data Cancer 48 (1981) 876-882

Livraghi, T , Bolondi, L , Lazzarom, S , Mann, G , Morabito, A , Rapaccim, GL, Salmi, A , Torzilh, G Percu­taneous ethanol injection in the treatment of hepatocellular carcinoma m cirrhosis Cancer 69 (1992) 925 929

Shuna, S , Tagawa, К , Unuma, T , Takanshi, R , Yoshiura, К , Komatsu, Y , Hata, Y , Niwa, Y , Shiraton, Y , Terano, A , Sugimoto, T Percutaneous ethanol injection therapy for hepatocellular carcinoma Cancer 68 (1991) 1524-1530

Kotoh, К , Sakai, S , Sakmoto, S , Nakayaraa, S , Satoh, M , Morotomi, I, Nawata, H The effect of percuta­neous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that ofhepate-ctomy Am J Gastroenterol 89 (1994) 194-198

Castells, A , Bruix, J , Вт, С , Fuster, J , Vilana, R , Navasa, iA , Ayuso, С , Boix, L , Visa, J , Rodes, J Treat­ment of small hepatocellular carcinoma m cirrfiotic patients a cohort study comparing surgical resection and percutaneous ethanol injection Hepatology 18 (1993) 1121-1126

Livraghi, T , Giorgio, A , Mann, G , Salmi, A , de Sio, I, Bolondi, L, Pompih, M , Brunello, F , Lazzarom, S , Torzilh, G Hepatocellular carcinoma and cirrhosis m 746 patients long term results of percutaneous etha­nol injection Radiology 197 (1995) 101-108

Lenciom, R , Bartolozzi, С , Caramella, D , Paohcchi, A , Carrai, M , Malttntt, G , Capita, A , Tafi, A , Conte, PF, Bevilacqua, G Treatment of small hepatocellular carcinoma with percutaneous ethanol injection Ana­lysis of prognostic factors tn 105 western patients Cancer 76 (1995) 1737-1746

Ohmshi, К , Nomura, F , Ito, S , Fujiwara, К Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection study of 91 cases Hepatology 23 (1996) 994-1002

Ohmshi, К , Yoshioka, H , Ito, S , Fujiwara, К Prospective randomized controlled trial comparing percutane­ous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma Hepatolo­gy 27 (1998) 67-72

Nagasue, N, Galiza, G , Kohno, H , Chang, YC, Hayahashi, T, Yamanoi, A , Nakamura, T, Yukaya, H Adverse effects ofpreoperative hepatic artery chemoembohzatton for resectable hepatocellular carcinoma a retrospective companson of 138 liver resections Surgery 106 (1989) 81-86

Izumt, R , Shimizu, К , lyobe, T , h, T , Yagi, M , Masui, О , Nonomura, A , Miyazaki, I Postoperative adju­vant hepatic artenal infusion oflipiodol containing anticancer drugs in patients with hepatocellular carcino­ma Hepatology 20 (1994) 295-301

Yamamoto, M , Aru, S , Sugahara, К , Tobe, T Adjuvant oral chemotherapy to prevent recurrence after cura­tive resection for hepatocellular carcinoma Br J Surgery 83 (1996) 336-340

Kanematsu, T , Matsumata, T , Furuta, T , Shirabe, К , Yamagata, M , Utsunomiya, T , Sugimachi, К Lipi-odol drug targeting m the treatment of primary hepatocellular carcinoma Hepato Gastroenterol 37 (1990) 442-444

Stefanim, GF, Amorati, P Biselh, M , Mucci, F , Celt, A , Anenti, V , Roversi, R , Rossi, С , Re, G , Gasbarnm, G , Efficacy oftransartenal targeted treatments on survival of patients with hepatocellular carcinoma Can­cer 75 (1995) 2427-2432

Groupe d Etude et de Traitement du Carcmome Hepatocellulaire A companson fo Lipiodol chemoembohzatton and conservative treatment for unresectable hepatocellular carcinoma N Engi J Med 332 (1995) 1256-1261

Kawai, S , Okamura, J , Ogawa, M (The cooperative study group for the liver cancer treatment of Japan) Prospective and randomized clinical tnal for the treatment fo hepatocellular carcinoma - a xompanson oflipiodol-transcatheter arterial embolization with and without adnamycm (first cooperative study) Can­cer Chemother Pharmacol 31 Suppi (1992) 1-6

Rossi, S., Di Stasi, M, Buscarini, E., Quaretti, P., Garbagnati, F., Squassante, L., Paties, CT, Siverman, DE, Buscarini, L.: Percutaneous radiofrequency interstitial thermal ablation in the treatment of hepatic cancer. AJR 167 (1996) 759-768

Koda, M., Okamoto, K., Miyoshi, Y., Kato, S., Murawaki, Y., Ilorie, Y., Suou, Т., Kawasaki, II.: Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepato­cellular carcinoma. Hepato Gastroenterol 41 (1994) 25-29

lshii, II., Okada, S., Okusaka, Т., Yoshimori, M., Nakasuka, II., Shimada, K., Yamasaki, S., Nakanishi, Y., Sakamoto, M.: Needle tract implantation ofhepatocellular carcinoma after percutaneous ethanol injection. Cancer 82 (1998) 1638-1642

CLIP Group (Cancer of the Liver Italian Program) : Tamoxifen in treatment ofhepatocellular carcinoma; a randomised controlled trial. Lancet 352 (1998) 17-20 : Kouroumalis, E., Skordilis, P., Thermos, K., Vasilaki, A., Moschandrea, J., Manousos, ON.: Treatment ofhepa­tocellular carcinoma with octreotide: a randomised controlled study. Gut 42 (1998) 442-447

Livraghi, Т., Benedini, V., Lazzaroni, S., Meloni, F., Torzilli, G., Vettori, C: Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83 (1998) 48-57

Llovet, JM., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, JC, Grande, L., Franca, А., Вт, C, Navasa, M., Ayuso, M., Sole, M., Real, MI., Vilana, R., Rimola, A., Visa, J., Rodes, J.: Liver transplantation for small hepatocellular carcinoma: the Tumor-Node-Metastasis Classification does not have prognostic po-; wer. Hepatology 27 (1998) 1572-1577
1   ...   41   42   43   44   45   46   47   48   49


написать администратору сайта